Anteris Technologies Global Corp. Common Stock (AVR) is a publicly traded Healthcare sector company. As of September 16, 2026, AVR trades at $8.38 with a market cap of $812.80M and a P/E ratio of -4.25. AVR moved -0.18% today. Year to date, AVR is +67.13%; over the trailing twelve months it is +43.30%. Its 52-week range spans $2.34 to $11.06. Analyst consensus is strong buy with an average price target of $15.33. Rallies surfaces AVR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest AVR news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $8.38 |
| Market Cap | $812.80M |
| P/E Ratio | -4.25 |
| EPS | $-1.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.06 |
| 52-Week Low | $2.34 |
| Volume | 510.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.24M |
| Net Income | $-102.91M |
| Gross Margin | 74.98% |
3 analysts cover AVR: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.33.